paymentsCash Flow (CF) Summary

Updated: 2026/03/31FY2026

Operating CF

63B JPY

YoY +153.6%

Investing CF

-57.5B JPY

YoY +6.1%

Financing CF

-8.2B JPY

YoY +72.3%

Free CF

5.5B JPY

YoY +115.1%

Cash Flow Trend (5 Years)

Investing CF

Operating CF

Financing CF

67.4億0

-61.2億

0000

67.4億

28.4億

-30億

2022

33.5億

-11.3億

-18.2億

2023

17.1億

14.9億

-39.4億

2024

24.9億

-61.2億

-29.6億

2025

63億

-57.5億

-8.2億

2026

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

77.5億38.8億0-38.8億-77.5億

20222023202420252026

waterfall_chartCash Flow Bridge (FY2026 Annual)

Beginning / Ending

Increase

Decrease

180億155億130億105億80億

103.9億

Opening Cash

63億

Operating CF

-57.5億

Investing CF

-8.2億

Financing CF

Other

101.3億

Closing Cash

ASKA Pharmaceutical Holdings Co.,Ltd.

paymentsCash Flow (CF) Summary

Cash Flow Trend (5 Years)

analyticsInvestment Efficiency Analysis

waterfall_chartCash Flow Bridge (FY2026 Annual)

Cash Flow Statement

Unlock Long-Term Financial Data